Use of Povetacicept in Treatment of IgA Nephropathy
Drs Jonathan Barratt and Brad Rovin comment on clinical trial data regarding the use of povetacicept for the treatment of IgAN.
Stay updated with breaking news from B Cell Modulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drs Jonathan Barratt and Brad Rovin comment on clinical trial data regarding the use of povetacicept for the treatment of IgAN.
Nephrology experts explore the role of dual inhibition of BlyS and APRIL in the treatment of IgAN, and how this can impact disease pathogenesis.
Brad Rovin, MD, outlines the use of complement inhibitors as an alternative to systemic glucocorticoids for the treatment of IgAN.
T follicular helper cells are specialized cells heavily involved in B cell modulation. Sino Biological has a wide range of high-quality cytokines that support R&D into therapeutic applications for Tfh cells.
Milwaukee, WI (PRWEB) May 18, 2022 -- SITC's "Targets for Cancer IO: A Deep Dive Series" Offers In-Depth Presentations on Cancer ImmunotherapyMILWAUKEE –